SR2640 (hydrochloride)

SR2640 (hydrochloride) is a potent and selective competitive leukotriene D4/leukotriene E4 antagonist. SR2640 can be used for researching the role of leukotrienes in human asthma[1].

Product Specifications

CAS Number

[146662-42-2]

UNSPSC

12352005

Target

Leukotriene Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/sr2640-hydrochloride.html

Purity

99.60

Solubility

DMSO : 250 mg/mL (ultrasonic)

Smiles

OC(C(C=CC=C1)=C1NC2=CC(OCC3=NC4=CC=CC=C4C=C3)=CC=C2)=O.[H]Cl

Molecular Formula

C23H19ClN2O3

Molecular Weight

406.86

References & Citations

[1]Ahnfelt-Rønne I, Kirstein D, Kaergaard-Nielsen C. A novel leukotriene D4/E4 antagonist, SR2640 (2-[3- (2-quinolylmethoxy) phenylamino]benzoic acid) . Eur J Pharmacol. 1988;155 (1-2) :117-128.